What are the key steps of damage control resuscitation for a patient with severe hemorrhagic trauma?

Damage Control Resuscitation in Severe Hemorrhagic Trauma

Damage control resuscitation (DCR) is a structured, simultaneous approach combining permissive hypotension, balanced hemostatic resuscitation with blood products, early tranexamic acid administration, and rapid surgical hemorrhage control to prevent the lethal triad of hypothermia, acidosis, and coagulopathy in severely bleeding trauma patients 1.

Initial Resuscitation Strategy

Hemodynamic Management

• Target systolic blood pressure of 80-90 mmHg (MAP 50-60 mmHg) using restricted volume replacement until bleeding is surgically controlled 1
• Exception: Maintain MAP ≥80 mmHg in severe traumatic brain injury (GCS <8) 1
• Add noradrenaline if fluid restriction fails to maintain target pressure 1
• Use crystalloid solutions (0.9% NaCl or balanced crystalloids); avoid hypotonic solutions like Ringer's lactate in severe head trauma 1

Immediate Hemostatic Resuscitation

The initial coagulation resuscitation must begin immediately with balanced blood product ratios 1:

• FFP:pRBC ratio of at least 1:2 (meaning 1 unit FFP for every 2 units pRBC minimum)
• High platelet:pRBC ratio should be applied
• Alternative: Fibrinogen concentrate or cryoprecipitate with pRBC

Tranexamic Acid Administration

Administer tranexamic acid as soon as possible, ideally en route to hospital 1:

• Loading dose: 1g IV over 10 minutes
• Maintenance: 1g IV infusion over 8 hours
• Must be given within 3 hours of injury
• Do not wait for viscoelastic test results before administration

Surgical Hemorrhage Control

Damage Control Surgery Indications

Perform damage control surgery when the patient presents with 1:

• Hemorrhagic shock with signs of ongoing bleeding
• Coagulopathy
• Hypothermia or acidosis
• Vascular or pancreatic injuries
• Combined abdominal inaccessible major anatomic injury
• Need for time-consuming procedures

Specific Interventions by Injury Pattern

Pelvic fractures:

• Apply pelvic binder in pre-hospital setting for suspected pelvic fracture 1
• Early pelvic ring closure and stabilization for pelvic ring disruption with hemorrhagic shock
• If bleeding continues or angioembolization unavailable: temporary extra-peritoneal packing ± open abdominal surgery 1

Non-compressible hemorrhage:

• Consider resuscitative endovascular balloon occlusion of the aorta (REBOA) for non-compressible life-threatening hemorrhage 1
• Use topical hemostatic agents combined with surgical measures for moderate arterial bleeding or venous/parenchymal injuries 1

Goal-Directed Coagulation Management

Fibrinogen Replacement

Initial dose: 3-4g fibrinogen concentrate (or 5-20 units cryoprecipitate) 1:

• Guide repeat doses by viscoelastic monitoring and/or laboratory fibrinogen levels
• Avoid FFP for isolated hypofibrinogenemia correction 1

Platelet Transfusion

• Maintain platelet count >50 × 10⁹/L in ongoing bleeding 1
• Maintain >100 × 10⁹/L in traumatic brain injury 1
• Initial dose: 4-8 single platelet units or one apheresis pack

Additional Coagulation Support

• Monitor and maintain ionized calcium in normal range; administer calcium chloride for hypocalcemia 1
• Consider prothrombin complex concentrate (PCC) if PT/APTT >1.5× normal with normal fibrinogen levels 1
• Factor XIII supplementation may be considered in bleeding patients with functional deficiency 1
• Recombinant factor VIIa: Only as last resort if major bleeding persists despite all other measures 1

Temperature Management

Implement early measures to prevent heat loss and actively warm hypothermic patients to achieve and maintain normothermia 1. Hypothermia is a critical component of the lethal triad and must be aggressively prevented.

Transfusion Targets

• Target hemoglobin: 70-90 g/L if erythrocyte transfusion necessary 1
• Consider cell salvage for severe bleeding from abdominal, pelvic, or thoracic cavities 1

Critical Pitfalls to Avoid

• Do not delay tranexamic acid waiting for laboratory results—administer empirically within 3 hours 1
• Do not use colloids due to adverse effects on hemostasis 1
• Do not target normal blood pressure in non-TBI patients before hemorrhage control—this increases bleeding 1
• Do not use FFP alone to correct fibrinogen deficiency—use fibrinogen concentrate or cryoprecipitate 1
• Do not perform time-consuming definitive repairs in unstable patients—abbreviate surgery and return to ICU for physiologic restoration 1

The evidence strongly supports that early transfusion initiation is critical—each 1-minute delay in transfusion is associated with increased mortality 2. This underscores the importance of activating massive transfusion protocols immediately upon recognition of hemorrhagic shock.